Schering Consent Decree Is Weighing Down Operations, CEO Says
This article was originally published in The Rose Sheet
Executive Summary
Schering-Plough's consumer division is among the hardest hit by the firm's ongoing FDA good manufacturing practices consent decree, according to the company